Zhang L, Zhuge Y, Ni J
BMC Immunol. 2025; 26(1):20.
PMID: 40069598
PMC: 11895216.
DOI: 10.1186/s12865-025-00698-4.
Ye G, Ye M, Jin X
Am J Cancer Res. 2024; 14(9):4113-4171.
PMID: 39417171
PMC: 11477829.
DOI: 10.62347/UJVP4361.
Wang T, Wang W
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023; 54(3):692-698.
PMID: 37248607
PMC: 10475433.
DOI: 10.12182/20230560108.
Li D, Lu J, Zhang Q, Zhou Y, Li L, Zhu H
BMC Chem. 2022; 16(1):75.
PMID: 36210464
PMC: 9549606.
DOI: 10.1186/s13065-022-00870-6.
Kang S, Khalil L, El-Rayes B, Akce M
Front Oncol. 2022; 12:821903.
PMID: 35433430
PMC: 9008732.
DOI: 10.3389/fonc.2022.821903.
3-Formylchromone Counteracts STAT3 Signaling Pathway by Elevating SHP-2 Expression in Hepatocellular Carcinoma.
Mohan C, Yang M, Rangappa S, Chinnathambi A, Alharbi S, Awad Alahmadi T
Biology (Basel). 2022; 11(1).
PMID: 35053027
PMC: 8773260.
DOI: 10.3390/biology11010029.
A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma.
Huo J, Cai J, Guan G, Liu H, Wu L
Front Cell Dev Biol. 2021; 9:761839.
PMID: 34869350
PMC: 8634890.
DOI: 10.3389/fcell.2021.761839.
Preclinical study to improve microbubble-mediated drug delivery in cancer using an ultrasonic probe with an interchangeable acoustic lens.
Lee S, Jeon H, Shim S, Im M, Kim J, Kim J
Sci Rep. 2021; 11(1):12654.
PMID: 34135427
PMC: 8209130.
DOI: 10.1038/s41598-021-92097-z.
and antitumor effects of lupeol-loaded galactosylated liposomes.
Zhang J, Hu X, Zheng G, Yao H, Liang H
Drug Deliv. 2021; 28(1):709-718.
PMID: 33825591
PMC: 8032341.
DOI: 10.1080/10717544.2021.1905749.
Upregulation of miR-138 Increases Sensitivity to Cisplatin in Hepatocellular Carcinoma by Regulating EZH2.
Zeng T, Luo L, Huang Y, Ye X, Lin J
Biomed Res Int. 2021; 2021:6665918.
PMID: 33748276
PMC: 7960019.
DOI: 10.1155/2021/6665918.
Reduction of Bladder Cancer Chemosensitivity Induced by the Effect of HOXA-AS3 as a ceRNA for miR-455-5p That Upregulates Notch1.
Chen D, Xie S, Wu Y, Cui Y, Cai Y, Lan L
Front Oncol. 2021; 10:572672.
PMID: 33643896
PMC: 7907523.
DOI: 10.3389/fonc.2020.572672.
Synergistic co-delivery of diacid metabolite of norcantharidin and ABT-737 based on folate-modified lipid bilayer-coated mesoporous silica nanoparticle against hepatic carcinoma.
Liu M, Tu J, Feng Y, Zhang J, Wu J
J Nanobiotechnology. 2020; 18(1):114.
PMID: 32811502
PMC: 7437073.
DOI: 10.1186/s12951-020-00677-4.
Overexpression of microRNA-9 enhances cisplatin sensitivity in hepatocellular carcinoma by regulating EIF5A2-mediated epithelial-mesenchymal transition.
Bao Y, Zhang Y, Lu Y, Guo H, Dong Z, Chen Q
Int J Biol Sci. 2020; 16(5):827-837.
PMID: 32071552
PMC: 7019138.
DOI: 10.7150/ijbs.32460.
Decreased cytoplasmic expression of Raptor correlates with disease progression and unfavorable prognosis in hepatocellular carcinoma.
Huang S, Lin X, Deng X, Luo X, Fang W, Luo R
Int J Clin Exp Pathol. 2020; 10(12):11789-11796.
PMID: 31966542
PMC: 6966046.
Azido-galactose outperforms azido-mannose for metabolic labeling and targeting of hepatocellular carcinoma.
Wang H, Liu Y, Xu M, Cheng J
Biomater Sci. 2019; 7(10):4166-4173.
PMID: 31368459
PMC: 6759386.
DOI: 10.1039/c9bm00898e.
Low‑intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR‑34a/c‑Met axis.
Li P, Zhang J, Li F, Yu Y, Chen Y
Int J Mol Med. 2019; 44(1):135-144.
PMID: 31115495
PMC: 6559300.
DOI: 10.3892/ijmm.2019.4205.
Efficacy of bevacizumab combined with erlotinib for advanced hepatocellular carcinoma: a single-arm meta-analysis based on prospective studies.
He L, Deng H, Lei J, Yi F, Li J, Fan X
BMC Cancer. 2019; 19(1):276.
PMID: 30922256
PMC: 6437948.
DOI: 10.1186/s12885-019-5487-6.
Ceramide-Graphene Oxide Nanoparticles Enhance Cytotoxicity and Decrease HCC Xenograft Development: A Novel Approach for Targeted Cancer Therapy.
Wang S, Ma Y, Chen X, Zhao Y, Mou X
Front Pharmacol. 2019; 10:69.
PMID: 30800068
PMC: 6376252.
DOI: 10.3389/fphar.2019.00069.
Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib.
Duan W, Liu Y
Drug Des Devel Ther. 2018; 12:2149-2161.
PMID: 30034219
PMC: 6047861.
DOI: 10.2147/DDDT.S166402.
Sphingosine kinase 1 overexpression is associated with poor prognosis and oxaliplatin resistance in hepatocellular carcinoma.
Wang F, Wu Z
Exp Ther Med. 2018; 15(6):5371-5376.
PMID: 29844803
PMC: 5958821.
DOI: 10.3892/etm.2018.6086.
